M.A.S. Med Global

Company Overview

Snapshot

Founded in July 2012 by Amit Ozery, Mark Perry, and Shaked Menashe, M.A.S. Med Global operated with 1–10 employees. The company was acquired by PerSys Medical in May 2018.

Business overview

M.A.S. Med Global specializes in developing medical solutions, with its core product being the TAQ-T (formerly ADAM Tourniquet), a fully automated pneumatic tourniquet. This device features an air-injected strap that inflates automatically to a precise pressure, aiming to reduce user error and facilitate effective tourniquet use by a broad audience, including untrained first-time users in emergency settings. The company serves markets within the Health Tech & Life Sciences sector, focusing on medical devices and equipment for critical care, defense, and law enforcement.

Strategic signal

In May 2018, M.A.S. Med Global was acquired by PerSys Medical. This acquisition signals a strategic consolidation within the medical device market, particularly for emergency and critical care solutions, indicating PerSys Medical's interest in integrating advanced automated tourniquet technology into its product portfolio and expanding its market reach.

Company Intelligence Q&A

What is M.A.S. Med Global's primary product?

M.A.S. Med Global's primary product is the TAQ-T, a fully automated pneumatic tourniquet designed for simple and practical medical solutions, particularly for controlling severe bleeding.

When was M.A.S. Med Global acquired?

M.A.S. Med Global was acquired by PerSys Medical in May 2018, leading to its inactive status.

Who founded M.A.S. Med Global?

M.A.S. Med Global was founded by Amit Ozery, Mark Perry, and Shaked Menashe in July 2012.

Which company acquired M.A.S. Med Global?

PerSys Medical, a multinational company, acquired M.A.S. Med Global in May 2018.

What was a key partnership for M.A.S. Med Global before its acquisition?

In July 2016, PerSys Medical partnered with M.A.S. Med Global Ltd., two years prior to the acquisition.